The Economic Burden Of Dasatinib And Nilotinib Treatment Failure In Chronic Myeloid Leukemia (Cml) Patients- A Real-World Analysis
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.669
https://www.valueinhealthjournal.com/article/S1098-3015(13)00740-7/fulltext
Section Title :
Cancer
Section Order :
217
First Page :
A137
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00740-7&doi=10.1016/j.jval.2013.03.669